Header
 
Search Website
GO
The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
 
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
 
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.
 
 

BCBA Bike Ride for Brain Cancer Fundraiser: 3-4 April 2020
 
Brain Cancer Biobanking Australia (BCBA) will hold their third 2 day fundraising Bike Ride for Brain Cancer – 240km from Sydney to the Hunter Valley -  3 and 4 April 2020. The date coincides with the birthday of Lucie Leonard, who died from brain cancer in 2012, and is the inspiration for the establishment of BCBA. For further information visit https://www.bikerideforbraincancer.com.au/.
 

Ideas or Concepts

COGNO is interested in developing new concepts into protocols and translating these into clinical research.

If you have a concept you are interested in developing, please complete this online form.

Recent News

24/01/2020: Quality of Life Office Using PROMs "Down Under" Conference
 

You may be interested in the following conference: Using PROMs "Down Under", 22-24 July 2020, Abercrombie Business School, University of Sydney

 more...
20/12/2019: COGNO Newsletter Issue 31 now available
 

Issue 31 of the COGNO Member Newsletter (Summer 2019) is now available for download from the COGNO Newsletters page.

 more...
24/10/2019: COGNO ASM: 3 days to go!
 

The 2019 COGNO ASM is just days away and we look forward to welcoming you. We have been fortunate enough to have a number of international speakers join us.

 more...